Other
Effective Income Tax Rate Reconciliation, FDII, Amount
Vertex Pharmaceuticals Effective Income Tax Rate Reconciliation, FDII, Amount remained flat by 0.0% to $14.63M in Q4 2025 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionOther
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2025
Last reportedQ4 2025Feb 13, 2026
How to read this metric
Higher values indicate successful utilization of tax incentives for foreign-derived income.
Detailed definition
This is the dollar amount of the tax benefit derived from the Foreign-Derived Intangible Income (FDII) deduction. It inc...
Peer comparison
Common for U.S. companies with significant international intellectual property and export sales.
Metric ID:
other_effective_income_tax_rate_reconciliation_fdii_amountHistorical Data
1 years
| FY'25 | |
|---|---|
| Value | $58.50M |
Effective Income Tax Rate Reconciliation, FDII, Amount at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's effective income tax rate reconciliation, fdii, amount?
- Vertex Pharmaceuticals (VRTX) reported effective income tax rate reconciliation, fdii, amount of $14.63M in Q4 2025.
- What does effective income tax rate reconciliation, fdii, amount mean?
- The tax savings generated by the FDII deduction for income earned from foreign sources using domestic assets.